Results 51 to 60 of about 15,411,498 (232)

Prevalence of Abnormal Papanicolaou Test Results and Related Factors among Women Living in Zanjan, Iran.

open access: yesAsian Pacific Journal of Cancer Prevention, 2015
BACKGROUND Currently, a comprehensive program for screening and early detection of cervical cancer does not exist in Iran. This study aimed to determine the prevalence of abnormal Papanicolaou (Pap) smears and some related factors among women living in ...
A. Maleki   +5 more
semanticscholar   +1 more source

Comparison of Nucleus and Cytoplasm Diameter of Buccal Mucosa Cells in Cigarette Smokers and Nonsmokers: A Cytomorphometric Study using Feulgen and Papanicolaou Stains

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2023
Introduction: A decrease in cell size and an increase in nuclear dimension due to changes in the amount of DNA could be an indicator of early detection of malignant changes.
MohammadJavad Hassanzadeh   +1 more
doaj  

High-risk Human Papillomavirus Testing for Triage of Women with Previous Cytological Abnormalities from the Vale do Ribeira Region [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 2020
Objective To evaluate the performance of the hybrid capture 2 (HC2) high-risk papillomavirus (hrHPV) assay and cytological test in women with previous abnormalities, to detect cervical intraepithelial neoplasia grade 2 or worse (≥ CIN 2).
Sandra Lorente   +5 more
doaj   +1 more source

Using the Papanicolaou (Pap) smear for cervical cancer screening in a tertiary care hospital: a prospective study and clinical correlation [PDF]

open access: yesJournal of Clinical and Basic Research, 2023
Background: Cervical cancer is the most frequent cause of death for women in developing countries. India, the second-most populous nation in the world, accounts for about 25% of cervical cancer deaths.
Devangkumar Patel   +2 more
doaj  

Willingness to Pay for New Papanicolaou Test Technologies [PDF]

open access: yesAmerican Journal of Clinical Pathology, 2002
The amount of money a woman is willing to pay for liquid-based cytology technology has not been measured. In the present study, 175 women answered a questionnaire asking how much they would pay to decrease their risk of dying of cervical cancer if a new (liquid-based) Papanicolaou (Pap) test was used in place of the conventional smear.
Stephen S, Raab   +5 more
openaire   +2 more sources

Accuracy of Human Papillomavirus (HPV) Test for Triage of Women with Atypical Squamous Cells of Undetermined Significance (ASCUS)

open access: yesمجله دانشکده پزشکی اصفهان, 2020
Background: In recent years, human papillomavirus (HPV) test has been approved in triage of women with Atypical Squamous Cells of Undetermined Significance (ASCUS).
Fariba Behnamfar   +2 more
doaj   +1 more source

THE PREVALENCE OF INTRA-EPITHELIAL LESIONS IN PREVENTIVE TESTS COL-LECTED BY STUDENT NURSES: 2008-2012

open access: yesCogitare Enfermagem, 2014
This study aimed to identify the prevalence of the diagnosis of intra-epithelial lesions, the age profile of the patients, and the principal microbiological and cellular changes described in the records of preventive tests collected by nursing students ...
Reginaldo Passoni dos Santos   +1 more
doaj   +1 more source

Papanicolaou Test in Women with Abnormal Bacteriologic Exam Results [PDF]

open access: diamond, 2022
I Costea   +3 more
openalex   +1 more source

Influence of human papillomavirus infection on the vaginal microbiome of women with immunocompetency

open access: yesDST, 2022
Introduction: The influence of vaginal infections on the natural history of human papillomavirus (HPV) is still unclear. Objective: To determine if patients with low-grade squamous intraepithelial lesions (LSILs) and HPV have more vulvovaginitis than ...
Karinne Cisne Fernandes Rebouças   +4 more
doaj  

Older Women's Willingness to Discontinue Papanicolaou Test Screening [PDF]

open access: yesThe Journal of the American Board of Family Medicine, 2014
We surveyed our patients to assess their willingness to discontinue Papanicolaou testing. Our findings differ from those of previous studies, with 72% of our eligible respondents voicing willingness to discontinue screening. There may be many reasons for this, including linking the recommendation with the name of the patient's own physician.
Ann, Skelton   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy